Establishing the Test-Retest Reliability and Minimal Detectable Change of the Multiple Sclerosis Resiliency Scale.

Q1 Nursing
International journal of MS care Pub Date : 2023-01-01 Epub Date: 2022-09-07 DOI:10.7224/1537-2073.2021-126
Elizabeth S Gromisch, Aaron P Turner, Lindsay O Neto, Jennifer A Ruiz, Albert C Lo, Thomas Agresta, Frederick W Foley
{"title":"Establishing the Test-Retest Reliability and Minimal Detectable Change of the Multiple Sclerosis Resiliency Scale.","authors":"Elizabeth S Gromisch,&nbsp;Aaron P Turner,&nbsp;Lindsay O Neto,&nbsp;Jennifer A Ruiz,&nbsp;Albert C Lo,&nbsp;Thomas Agresta,&nbsp;Frederick W Foley","doi":"10.7224/1537-2073.2021-126","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Multiple Sclerosis Resiliency Scale (MSRS) was designed to assess factors connected to resilience when facing MS-related challenges. Although the MSRS has demonstrated good internal consistency and construct validity, its test-retest reliability has yet to be established. Identifying the minimal detectable change (MDC) of the scale will also improve its utility as an outcome measure for resilience-based interventions. This study aimed to determine the test-retest reliability and MDC of the MSRS.</p><p><strong>Methods: </strong>Participants were 62 persons with MS who completed the MSRS twice, with a mean ± SD of 16.60 ± 3.97 days (range, 14-30 days) between assessments. Test-retest reliability was evaluated using a 2-way, random-effects, single-measurement intraclass correlation coefficient (ICC), with agreement between time 1 and time 2 visualized with a Bland-Altman plot. The MDC was calculated using the standard error of measurement with a 95% CI.</p><p><strong>Results: </strong>At time 1, the mean ± SD MSRS score was 77.19 ± 11.97 (range, 45.83-97.00); at time 2, the mean ± SD score was 76.38 ± 12.75 (range, 46-98). The MSRS total score had good test-retest reliability (ICC = 0.88), with the subscale ICCs ranging from 0.77 (MS Peer Support) to 0.93 (Spirituality). The MDC for the total score was 11.95.</p><p><strong>Conclusions: </strong>These findings suggest that the MSRS has good test-retest reliability and that persons with MS with a difference of 12 points or more between assessments have experienced a reliable change. The results support the utility of the MSRS as a potential outcome measure for MS-related resilience.</p>","PeriodicalId":14150,"journal":{"name":"International journal of MS care","volume":"25 1","pages":"15-19"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881417/pdf/i1537-2073-25-1-15.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of MS care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7224/1537-2073.2021-126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/9/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 1

Abstract

Background: The Multiple Sclerosis Resiliency Scale (MSRS) was designed to assess factors connected to resilience when facing MS-related challenges. Although the MSRS has demonstrated good internal consistency and construct validity, its test-retest reliability has yet to be established. Identifying the minimal detectable change (MDC) of the scale will also improve its utility as an outcome measure for resilience-based interventions. This study aimed to determine the test-retest reliability and MDC of the MSRS.

Methods: Participants were 62 persons with MS who completed the MSRS twice, with a mean ± SD of 16.60 ± 3.97 days (range, 14-30 days) between assessments. Test-retest reliability was evaluated using a 2-way, random-effects, single-measurement intraclass correlation coefficient (ICC), with agreement between time 1 and time 2 visualized with a Bland-Altman plot. The MDC was calculated using the standard error of measurement with a 95% CI.

Results: At time 1, the mean ± SD MSRS score was 77.19 ± 11.97 (range, 45.83-97.00); at time 2, the mean ± SD score was 76.38 ± 12.75 (range, 46-98). The MSRS total score had good test-retest reliability (ICC = 0.88), with the subscale ICCs ranging from 0.77 (MS Peer Support) to 0.93 (Spirituality). The MDC for the total score was 11.95.

Conclusions: These findings suggest that the MSRS has good test-retest reliability and that persons with MS with a difference of 12 points or more between assessments have experienced a reliable change. The results support the utility of the MSRS as a potential outcome measure for MS-related resilience.

建立多发性硬化恢复力量表的测试-复验可靠性和最小可检测变化。
背景:多发性硬化症恢复力量表(MSRS)旨在评估在面临MS相关挑战时与恢复力相关的因素。尽管MSRS已经证明了良好的内部一致性和结构有效性,但其重新测试的可靠性尚待确定。确定量表的最小可检测变化(MDC)也将提高其作为基于复原力的干预措施的结果衡量标准的效用。本研究旨在确定MSRS的重测可靠性和MDC。方法:参与者为62名MS患者,他们完成了两次MSRS,两次评估之间的平均±SD为16.60±3.97天(范围为14-30天)。使用双向随机效应单次测量组内相关系数(ICC)评估测试-再测试的可靠性,时间1和时间2之间的一致性通过Bland-Altman图进行可视化。MDC采用95%置信区间的标准测量误差计算。结果:在时间1,平均±SD MSRS评分为77.19±11.97(范围为45.83-97.00);在时间2,平均±SD评分为76.38±12.75(范围46-98)。MSRS总分具有良好的重测可靠性(ICC=0.88),分量表ICCs在0.77(MS同伴支持)到0.93(精神)之间。总分的MDC为11.95。结论:这些发现表明MSRS具有良好的重测可靠性,并且两次评估之间相差12分或更多的MS患者经历了可靠的变化。研究结果支持MSRS作为MS相关恢复力的潜在结果衡量标准的效用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International journal of MS care
International journal of MS care Nursing-Advanced and Specialized Nursing
CiteScore
3.00
自引率
0.00%
发文量
40
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信